Skip to main content
Equibles
NVO logo

NVO · Novo Nordisk A S

Track NVO — free

Use NVO with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about NVO

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$45.89 -0.83 (-1.78%) At close · Aug 14
Market Cap
$201.05B
Shares
4.38B

Novo Nordisk A S Earnings Call Transcripts

Every quarterly earnings call for Novo Nordisk A S (NVO) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Earnings call
FY25 · Q4
2025-12-31
Novo Nordisk A S Q4 FY2025 Earnings Call
Positive tone Wegovy pill launch Obesity care growth Pipeline readouts and approvals
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-09-30
Novo Nordisk A S Q3 FY2025 Earnings Call
Balanced tone Strategic focus on diabetes and obesity GLP-1 franchise performance (Ozempic, Wegovy, Rybelsus) Business development and M&A (Akero, Metsera)
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-06-30
Novo Nordisk A S Q2 FY2025 Earnings Call
Cautious tone Obesity care / Wegovy Pipeline and R&D GLP-1 diabetes / Ozempic
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-03-31
Novo Nordisk A S Q1 FY2025 Earnings Call
Positive tone GLP-1 volume leadership and patient growth Wegovy U.S. obesity growth Compounding impact and guidance cut
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q3
2024-09-30
Novo Nordisk A S Q3 FY2024 Earnings Call
Confident tone GLP-1 scaling and patient reach Pipeline and R&D readouts Obesity care growth
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-06-30
Novo Nordisk A S Q2 FY2024 Earnings Call
Confident tone GLP-1 franchise (Ozempic, Wegovy, Rybelsus) Obesity Care and Wegovy supply Sustainability and patients reached
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-03-31
Novo Nordisk A S Q1 FY2024 Earnings Call
Confident tone Obesity supply expansion (Wegovy) GLP-1 sales momentum R&D pipeline and readouts
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
Novo Nordisk A S Q4 FY2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-09-30
Novo Nordisk A S Q3 FY2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-06-30
Novo Nordisk A S Q2 FY2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-03-31
Novo Nordisk A S Q1 FY2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-12-31
Novo Nordisk A S Q4 FY2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-09-30
Novo Nordisk A S Q3 FY2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-06-30
Novo Nordisk A S Q2 FY2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-03-31
Novo Nordisk A S Q1 FY2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2021-12-31
Novo Nordisk A S Q4 FY2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-09-30
Novo Nordisk A S Q3 FY2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-06-30
Novo Nordisk A S Q2 FY2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-03-31
Novo Nordisk A S Q1 FY2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2020-12-31
Novo Nordisk A S Q4 FY2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-09-30
Novo Nordisk A S Q3 FY2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-06-30
Novo Nordisk A S Q2 FY2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-03-31
Novo Nordisk A S Q1 FY2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Showing 1–23 of 23 earnings calls
Key facts CIK 353278 CUSIP 670100205 13F (30d) 1204 filings 1158 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)